Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study
Eduardo A. Oliveira, Maria Christina L. Oliveira, Enrico A. Colosimo, Ana Cristina Simões e Silva, Robert H. Mak, Mariana A. Vasconcelos, Ludmila R. Silva, Daniella Reis Barbosa Martelli, Clara C. Pinhati, Hercílio Martelli‐Júnior
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)VaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PediatricsPopulationIntensive care unitInternal medicineImmunologyDiseaseInfectious disease (medical specialty)Environmental healthSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyImmune responses and vaccinations